Gender‐specific correlations of plasminogen activator inhibitor‐1 and tissue plasminogen activator levels with cardiovascular disease‐related traits

This publication has 40 references indexed in Scilit:

• UNRESOLVED ISSUES IN DIALYSIS: Inflammatory Biomarkers and Cardiovascular Risk: Association or Cause and Effect?
  Seminars in Dialysis, 2006
• The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels
  Thrombosis and Haemostasis, 2006
• Acute and chronic effects of oestrogen on endothelial tissue‐type plasminogen activator release in postmenopausal women
  The Journal of Physiology, 2003
• Cardiovascular Risk Factors Are Differently Associated with Urinary Albumin Excretion in Men and Women
  Journal of the American Society of Nephrology, 2003
• Gender Differences in the Relationships Between Plasma Plasminogen Activator Inhibitor-1 Activity and Factors Linked to the Insulin Resistance Syndrome in Essential Hypertension
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Endogenous tissue-type plasminogen activator and risk of myocardial infarction
  The Lancet, 1993
• Influence of age and menopause on serum lipids and lipoproteins in healthy women
  Atherosclerosis, 1993
• Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women.
  Stroke, 1990
• PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
  The Lancet, 1987